Evo Fund raises stake in Modalis Therapeutics to 31.76%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-08-30 15:09 JST concerning Modalis Therapeutics Corporation. Reported holding ratio: 31.76%, previous report: 5.42%.